Меню
Набор скоро начнётся NCT06766331

Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans

Без фазы С лечением Opioid Use Disorder HIV Hepatitis C Virus Gonorrhea

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Integrated care.
Кому может быть актуально
Состояния в реестре: Opioid Use Disorder, HIV, Hepatitis C Virus, Gonorrhea. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Integrating Infectious Diseases Screening and Treatment With Medication Assisted Therapy for Veterans With Opioid Use Disorder

Обзор

Opioid use disorder (OUD) confers a higher risk of acquiring and transmitting infectious diseases, which may have long-term health consequences in Veterans. Treatment of OUD with medication assisted therapy is highly effective, however this often occurs independently of infectious diseases care. This project will test out a new model that combines infectious diseases and OUD care within one VA clinic appointment. This new care model may improve the health of Veterans and reduce cost and time required for Veterans who often need to attend multiple outpatient appointments.

Подробное описание

Opioid use disorder (OUD) is associated with increased risk for overdose as well as acquisition and transmission of infectious diseases (ID), including HIV, hepatitis C virus (HCV), and bacterial sexually transmitted infections (STI). Previous studies support improved clinical outcomes when integrating treatment for OUD and screening and treatment of HIV and HCV in non-Veteran populations. However, clinical care for Veterans with OUD often requires appointments with multiple different healthcare providers. These care silos place an increased burden on this patient population who often have barriers to appointment attendance. Improved integration OUD and ID clinical care is needed. In a recent study of Veterans with OUD who accessed care at the Northport VA (Long Island, NY) the investigators identified 216 (43%) Veterans who had a history of injecting drug use and of those, 134 (62%) had HCV and 30 (13.9%) had at least one severe injection related infection requiring hospitalization. The investigators also found low rates of screening for bacterial sexually transmitted infections, including syphilis (n=371, 74%), gonorrhea (n=160, 31.9%), chlamydia (n=169, 33.7%) and low uptake of HIV pre-exposure prophylaxis (PrEP) (n=4, 0.8%). In this pilot study, the investigators will assess the feasibility and acceptability of an integrated ID screening and PrEP intervention for Veterans with OUD who are engaged in care through the Northport VA SUD clinic. The investigators will randomize Veterans to receive either integrated care (HIV, HCV, STI screening and/or PrEP plus SUD care) or treatment as usual (SUD care plus ID clinic referral). The investigators will also compare rates of HIV, HCV and bacterial STI screening as well as PrEP uptake between the groups. This research will benefit male and female Veterans with OUD. This project will be carried out at the Northport Veterans Affairs Medical Center (NVAMC). Information obtained from this study will be utilized to inform a larger multi-site VA trial assessing the efficacy of IC versus usual care.

Вмешательства

  • Другое Integrated care
    Receipt of infectious diseases laboratory testing and/or PrEP for HIV within a single substance use disorder clinic appointment.

Первичные конечные точки

  • Infectious diseases screening uptake during intervention period [Срок оценки: 90 days]
Вторичные конечные точки (12)
  • PrEP uptake during intervention period [Срок оценки: 90 days]
  • HIV screening uptake during intervention period [Срок оценки: 90 days]
  • HCV screening uptake during intervention period [Срок оценки: 90 days]
  • Gonorrhea screening uptake during intervention period [Срок оценки: 90 days]
  • Chlamydia screening uptake during intervention period [Срок оценки: 90 days]
  • Syphilis screening uptake during intervention period [Срок оценки: 90 days]
  • PrEP uptake during follow-up period [Срок оценки: 270 days]
  • HIV screening uptake during follow-up period [Срок оценки: 270 days]
  • HCV screening uptake during follow-up period [Срок оценки: 270 days]
  • Gonorrhea screening uptake during follow-up period [Срок оценки: 270 days]
  • Chlamydia screening uptake during follow-up period [Срок оценки: 270 days]
  • Syphilis screening uptake during follow-up period [Срок оценки: 270 days]

Критерии участия

Критерии включения

  • US Veteran
  • Able to provide written informed consent in English
  • Living in the community (Nassau, Suffolk, Kings, Queens, Bronx, Westchester, Rockland counties, NY)
  • Documented diagnosis of moderate to severe opioid use disorder
  • Seeking care at the Northport VA substance use disorder clinic for opioid use disorder treatment
  • Willing to have HIV, HBV, HCV, or bacterial STI testing to determine negative or positive status
  • Persons who test negative for HIV need to meet CDC PrEP eligibility criteria in the 6 months prior to enrollment

Критерии исключения

  • Severe medical or psychiatric disability making participation unsafe
  • Unable to provide written consent
  • PrEP exclusion: HIV positive test; HBV positive test

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Скрининг

Центры проведения

США · 1 центр
  • Northport VA Medical Center, Northport, NY — Northport

Идентификаторы

NCT: NCT06766331 · INFA-010-24S · 1IK2CX002822-01A1

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗